Matthew McMenemy is an Ophthalmology physician. OpenAlex indexes 10 publications with 466 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
34 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Bausch & Lomb Americas Inc.Program year202535 payments$27,723openpaymentsdata.cms.gov ↗
- Alcon Vision LLCProgram year202520 payments
- SUN PHARMACEUTICAL INDUSTRIES INC.Program year202512 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
79.2%Prostaglandin Analog43.1%Latanoprost90%Travoprost5%Lumigan4%Travatan Z0%Part D<11 patientsCarbonic Anhydrase Inhibitor9.2%Dorzolamide-Timolol74%Simbrinza10%Dorzolamide Hcl7%Brinzolamide4%Acetazolamide3%Acetazolamide Er2%Part D<11 patients+ 11 more classes in this area
Anti-infectives
9%Fluoroquinolone Antibacterial6.4%Moxifloxacin100%Part D≥291 patientsMacrolide Antimicrobial1.3%Azithromycin100%Part D≥83 patients+ 4 more classes in this area
Musculoskeletal
5.9%Cyclooxygenase Inhibitor5.9%Ketorolac Tromethamine100%Part D≥259 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Netarsudil/Latanoprost Fixed-Dose Combination for Elevated Intraocular Pressure: Three-Month Data from a Randomized Phase 3 Trial
American Journal of Ophthalmology
2019 - Evaluation of the efficacy and safety of latanoprost 0.005% without benzalkonium chloride and its noninferiority to latanoprost 0.005% with benzalkonium chloride in patients with open-angle glaucoma and ocular hypertension2019
- A Randomized Trial of Fixed-Dose Combination Brinzolamide 1%/Brimonidine 0.2% as Adjunctive Therapy to Travoprost 0.004%
American Journal of Ophthalmology
2016 - Demographic Subgroup Analysis in a Study Comparing the Additive Effect of Brinzolamide 1%/Brimonidine 0.2% in Patients with Open-Angle Glaucoma or Ocular Hypertension Treated with TRAVATAN Z® (NCT01937299)2015
- Phase 3 Randomized 3-Month Trial with an Ongoing 3-Month Safety Extension of Fixed-Combination Brinzolamide 1%/Brimonidine 0.2%
Journal of Ocular Pharmacology and Therapeutics
2013
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Emily Chew, MD
National Eye Institute
Robert Weinreb, MD
University of California San Diego
Harry Quigley, MD
Johns Hopkins University School of Medicine
Joel Schuman, MD
Wills Eye Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”